ArticleAnnals of Saudi medicine

Cost-effectiveness of oral agents in relapsing-remitting multiple sclerosis compared to interferon-based therapy in Saudi Arabia.

Mai F Alsaqa'aby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.